158 related articles for article (PubMed ID: 26277630)
1. Immunohistopathological analysis of frizzled-4-positive immature melanocytes from hair follicles of patients with Rhododenol-induced leukoderma.
Okamura K; Ohe R; Abe Y; Ueki M; Hozumi Y; Tamiya G; Matsunaga K; Yamakawa M; Suzuki T
J Dermatol Sci; 2015 Nov; 80(2):156-8. PubMed ID: 26277630
[No Abstract] [Full Text] [Related]
2. The effect of rhododendrol inhibition of NF-κB on melanocytes in the presence of tyrosinase.
Arase N; Yang L; Tanemura A; Yang F; Suenaga T; Arase H; Katayama I
J Dermatol Sci; 2016 Aug; 83(2):157-9. PubMed ID: 27174091
[No Abstract] [Full Text] [Related]
3. Immunohistochemical analysis of rhododendrol-induced leukoderma in improved and aggravated cases.
Yasuda M; Sekiguchi A; Kishi C; Toki S; Arase N; Takahashi A; Yang F; Tanemura A; Hayashi M; Abe Y; Hamada T; Suzuki T; Katayama I; Ishikawa O
J Dermatol Sci; 2020 Aug; 99(2):140-143. PubMed ID: 32653297
[No Abstract] [Full Text] [Related]
4. Guide for medical professionals (i.e., dermatologists) for the management of Rhododenol-induced leukoderma.
Nishigori C; Aoyama Y; Ito A; Suzuki K; Suzuki T; Tanemura A; Ito M; Katayama I; Oiso N; Kagohashi Y; Sugiura S; Fukai K; Funasaka Y; Yamashita T; Matsunaga K
J Dermatol; 2015 Feb; 42(2):113-28. PubMed ID: 25622988
[TBL] [Abstract][Full Text] [Related]
5. Leukoderma induced by rhododendrol is different from leukoderma of vitiligo in pathogenesis: A novel comparative morphological study.
Tsutsumi R; Sugita K; Abe Y; Hozumi Y; Suzuki T; Yamada N; Yoshida Y; Yamamoto O
J Cutan Pathol; 2019 Feb; 46(2):123-129. PubMed ID: 30456919
[TBL] [Abstract][Full Text] [Related]
6. Open-label pilot study to evaluate the effectiveness of topical bimatoprost on rhododendrol-induced refractory leukoderma.
Fukaya S; Kamata M; Kasanuki T; Yokobori M; Takeoka S; Hayashi K; Tanaka T; Fukuyasu A; Ishikawa T; Ohnishi T; Iimuro S; Tada Y; Watanabe S
J Dermatol; 2018 Nov; 45(11):1283-1288. PubMed ID: 30156328
[TBL] [Abstract][Full Text] [Related]
7. Rhododenol-induced leukoderma in a mouse model mimicking Japanese skin.
Abe Y; Okamura K; Kawaguchi M; Hozumi Y; Aoki H; Kunisada T; Ito S; Wakamatsu K; Matsunaga K; Suzuki T
J Dermatol Sci; 2016 Jan; 81(1):35-43. PubMed ID: 26547111
[TBL] [Abstract][Full Text] [Related]
8. Systemic skin whitening/lightening agents: what is the evidence?
Malathi M; Thappa DM
Indian J Dermatol Venereol Leprol; 2013; 79(6):842-6. PubMed ID: 24177629
[No Abstract] [Full Text] [Related]
9. Preservation of melanoblasts of white hair follicles of segmental vitiligo lesions: A preliminary study.
Song HJ; Choi GS; Shin JH
J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):240-2. PubMed ID: 20497288
[No Abstract] [Full Text] [Related]
10. Autoantibodies detected in patients with vitiligo vulgaris but not in those with rhododendrol-induced leukoderma.
Arase N; Tanemura A; Jin H; Nishioka M; Aoyama Y; Oiso N; Matsunaga K; Suzuki T; Nishigori C; Kawamura T; Shimizu T; Ito A; Fukai K; Abe Y; Yang L; Tsuruta D; Takeoka K; Iwatani Y; Hidaka Y; Nishida M; Yamauchi-Takihara K; Arase H; Fujimoto M; Katayama I
J Dermatol Sci; 2019 Aug; 95(2):80-83. PubMed ID: 31399283
[No Abstract] [Full Text] [Related]
11. An immune pathological and ultrastructural skin analysis for rhododenol-induced leukoderma patients.
Tanemura A; Yang L; Yang F; Nagata Y; Wataya-Kaneda M; Fukai K; Tsuruta D; Ohe R; Yamakawa M; Suzuki T; Katayama I
J Dermatol Sci; 2015 Mar; 77(3):185-8. PubMed ID: 25676426
[TBL] [Abstract][Full Text] [Related]
12. Retention of pigment stem cells in Rhododenol-induced leukoderma: Pathological investigation of 11 patients.
Watanabe S; Yagami A; Iwata Y; Nagai A; Kuroda M; Sugiura K; Matsunaga K
J Dermatol; 2017 Jul; 44(7):e148-e149. PubMed ID: 28516676
[No Abstract] [Full Text] [Related]
13. The hair follicle melanocytes in vitiligo in relation to disease duration.
Anbar TS; Abdel-Raouf H; Awad SS; Ragaie MH; Abdel-Rahman AT
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):934-9. PubMed ID: 19453793
[TBL] [Abstract][Full Text] [Related]
14. Substantial evidence for the rhododendrol-induced generation of hydroxyl radicals that causes melanocyte cytotoxicity and induces chemical leukoderma.
Gabe Y; Miyaji A; Kohno M; Hachiya A; Moriwaki S; Baba T
J Dermatol Sci; 2018 Sep; 91(3):311-316. PubMed ID: 30005897
[TBL] [Abstract][Full Text] [Related]
15. Depigmentation of the skin induced by 4-(4-hydroxyphenyl)-2-butanol is spontaneously re-pigmented in brown and black guinea pigs.
Kuroda Y; Takahashi Y; Sakaguchi H; Matsunaga K; Suzuki T
J Toxicol Sci; 2014 Aug; 39(4):615-23. PubMed ID: 25056786
[TBL] [Abstract][Full Text] [Related]
16. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
[TBL] [Abstract][Full Text] [Related]
17. Accelerating bleaching in vitiligo: balancing benefits versus risks.
Seneschal J; Boniface K; Ezzedine K; Taieb A
Exp Dermatol; 2014 Dec; 23(12):879-80. PubMed ID: 25039467
[TBL] [Abstract][Full Text] [Related]
18. Rhododenol Activates Melanocytes and Induces Morphological Alteration at Sub-Cytotoxic Levels.
Kim M; Lee CS; Lim KM
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31726751
[TBL] [Abstract][Full Text] [Related]
19. Rhododendrol-induced leukoderma accompanied by allergic contact dermatitis caused by a non-rhododendrol skin-lightening agent, 5,5'-dipropylbiphenyl-2,2'-diol.
Yagami A; Suzuki K; Sano A; Takahashi M; Kobayashi T; Morita Y; Ando A; Iwata Y; Matsunaga K
J Dermatol; 2015 Jul; 42(7):739-40. PubMed ID: 25875673
[No Abstract] [Full Text] [Related]
20. Clinical and epidemiological analysis in 149 cases of rhododendrol-induced leukoderma.
Yoshikawa M; Sumikawa Y; Hida T; Kamiya T; Kase K; Ishii-Osai Y; Kato J; Kan Y; Kamiya S; Sato Y; Yamashita T
J Dermatol; 2017 May; 44(5):582-587. PubMed ID: 27882588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
